Drug Search Results
More Filters [+]


Alternative Names: demeclocycline, declomycin
Latest Update: 2022-05-20
Latest Update Note: Clinical Trial Update

Product Description

Demeclocycline is a semisynthetic tetracycline derived from Streptococcus aureofaciens that is used as an antibiotic, but perhaps more frequently as an inhibitor of arginine vasopressin in the therapy of hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). (Sourced from: https://www.ncbi.nlm.nih.gov/books/NBK548848/)

Mechanisms of Action: 30S Ribosomal Subunit Inhibitor,Protein Synthesis Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intramuscular,Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Austria | Bangladesh | Brazil | Canada | Colombia | Dominican Republic | Ecuador | France | Greece | Hong Kong | India | Ireland | Italy | Malta | Mexico | New Zealand | Pakistan | Peru | Taiwan | Thailand | United Kingdom | United States | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Demeclocycline

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases



Trial Status


Primary Completion Date

Probability of Success

Recent News Events